Translational Cancer Immunology


The Laboratory for Translational Cancer Immunology develops cellular- and antibody-based immunotherapies for malignant neoplasia, with a special focus on acute leukemia and B-cell lymphoma. We seek to better understand mechanisms of action and resistance with the goal to identify predicitive biomarkers for selecting the suitable immunotherapy for each individual patient.

  • -